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Fig. S1 
Cell cycle analysis of neuroblastoma cell lines treated with 20nM camptothecin (CPT) 
or topotecan (TPT) and harvested at different time points, as indicated. The 
percentages of cells with hypodyploid DNA or in the dfferent phases of the cell cycle 
are indicated. (A) neuroblastoma cell lines without amplification of MYCN; (B) 
neuroblastoma cell lines with amplification of MYCN,  
Supplementary Figure 2: Cell cycle analysis of neuroblastoma cell lines treated with 20nM camptothecin (CPT) or 
topotecan (TPT) and harvested at different time points, as indicated. The percentages of cells with hypodyploid DNA or in the 
dfferent phases of the cell cycle are indicated. (A) neuroblastoma cell lines without amplification of MYCN; (B) neuroblastoma cell lines 
with amplification of MYCN.
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A SPECIFIC INHIBITOR OF THE B-MYB/MYCN AXIS IN NEUROBLASTOMA.







Fig. S2. Expression of Topoisomerase-1 in neuroblastoma cells. The expression of 
Topoisomerase-1 was quantified by western analysis with an antibody. The bars show 
the values of the densitometric units of topoisomerase-1 bands relative to GAPDH, 
used to normalise the expression. GIMEN, SH-SY5Y and SKNAS cells are MYCN 
negative cell lines. IMR-32, Kelly, LAN-5 and SK-N-BE2 are MYCN amplified cell 












Supplementary Figure 2: Expression of Topoisomerase-1 in neuroblastoma cells. The expression of Topoisomerase-1 was 
quantified by western analysis with an antibody. The bars show the values of the densitometric units of topoisomerase-1 bands relative to 
GAPDH, used to normalize the expression. GIMEN, SH-SY5Y and SKNAS cells are MYCN negative cell lines. IMR-32, Kelly, LAN-5 
and SK-N-BE2 are MYCN amplified cell lines. K-562 cells were used as positive control.
 
 
Fig. S3. Western blot analysis showing the expression of B-MYB in control or B-
MYB transfected cell lines.  
 
	  
Supplementary Figure 3: Western blot analysis showing the expression of B-MYB in control or BMYB transfected 
cell lines.
